{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:23:51Z","timestamp":1785151431940,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent advances in tumor metabolism have revealed that metabolic reprogramming could dramatically promote caner metastasis. However, the relation and mechanism between metastasis and metabolic reprogramming are not thoroughly explored. Cell proliferation, colony formation, and invasion analysis were performed to evaluate the role of FAM210B in human cancer cells. Human ovarian cancer xenograft model was used to determine the effects of inhibiting FAM210B by shRNA on tumor metastasis. Microarray analysis was used to determine the target genes of FAM210B. FAM210B cellular localization was performed by mitochondria isolation and mitochondria protein extraction. To detect FAM210B-mediated metabolic reprogramming, oxygen consumption rate and extracellular acidification rate were measured. Our previous study screened a novel cancer progression-suppressor gene, FAM210B, which encodes an outer mitochondrial membrane protein, by the suppression of mortality by antisense rescue technique (SMART). Here we demonstrated that FAM210B loss was significantly associated with cancer metastasis and decreased survival in a clinical setting. Additionally, it was found that low expression of FAM210B was significantly correlated with decreased survival and enhanced metastasis <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>, and the loss of FAM210B led to an increased mitochondrial respiratory capacity and reduced glycolysis through the downregulation of pyruvate dehydrogenase kinase 4 (PDK4), which activated the EMT program and enhanced migratory and invasive properties. Collectively, our data unveil a potential metabolic target and mechanism of cancer metastasis.<\/jats:p>","DOI":"10.1038\/cddis.2017.273","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T12:42:52Z","timestamp":1496925772000},"page":"e2870-e2870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming"],"prefix":"10.1038","volume":"8","author":[{"given":"Shujuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meisong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"BFcddis2017273_CR1","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson GC, Kohn EC, Kitchener HC, Ledermann JA . Ovarian cancer. Lancet 2014; 384: 1376\u20131388.","journal-title":"Lancet"},{"key":"BFcddis2017273_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"RC Bast Jr","year":"2009","unstructured":"Bast RC Jr, Hennessy B, Mills GB . The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 2009; 9: 415\u2013428.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2017273_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nrc1611","volume":"5","author":"H Naora","year":"2005","unstructured":"Naora H, Montell DJ . Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005; 5: 355\u2013366.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2017273_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nrm2972","volume":"11","author":"MR Buchakjian","year":"2010","unstructured":"Buchakjian MR, Kornbluth S . The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 2010; 11: 715\u2013727.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2017273_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFcddis2017273_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J . Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 472\u2013482.","journal-title":"Cancer Cell"},{"key":"BFcddis2017273_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-015-0128-2","volume":"3","author":"CS Ahn","year":"2015","unstructured":"Ahn CS, Metallo CM . Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab 2015; 3: 1.","journal-title":"Cancer Metab"},{"key":"BFcddis2017273_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","volume":"22","author":"F Dupuy","year":"2015","unstructured":"Dupuy F, Tabaries S, Andrzejewski S, Dong Z, Blagih J, Annis MG et al. PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer. Cell Metab 2015; 22: 577\u2013589.","journal-title":"Cell Metab"},{"key":"BFcddis2017273_CR9","first-page":"1001","volume":"16","author":"VS LeBleu","year":"2014","unstructured":"LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 2014; 16: 1001\u20131015.","journal-title":"Nat Cell Biol"},{"key":"BFcddis2017273_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB . Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 2012; 21: 297\u2013308.","journal-title":"Cancer Cell"},{"key":"BFcddis2017273_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrm3305","volume":"13","author":"KE Wellen","year":"2012","unstructured":"Wellen KE, Thompson CB . A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 2012; 13: 270\u2013276.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2017273_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cdd.2009.142","volume":"17","author":"P Wu","year":"2010","unstructured":"Wu P, Tian Y, Chen G, Wang B, Gui L, Xi L et al. Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. Cell Death Differ 2010; 17: 109\u2013118.","journal-title":"Cell Death Differ"},{"key":"BFcddis2017273_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.stem.2012.10.011","volume":"12","author":"K Takubo","year":"2013","unstructured":"Takubo K, Nagamatsu G, Kobayashi CI, Nakamura-Ishizu A, Kobayashi H, Ikeda E et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 2013; 12: 49\u201361.","journal-title":"Cell Stem Cell"},{"key":"BFcddis2017273_CR14","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1158\/0008-5472.CAN-15-0706","volume":"75","author":"Y Liu","year":"2015","unstructured":"Liu Y, Metzinger MN, Lewellen KA, Cripps SN, Carey KD, Harper EI et al. Obesity contributes to ovarian cancer metastatic success through increased lipogenesis, enhanced vascularity, and decreased infiltration of M1 macrophages. Cancer Res 2015; 75: 5046\u20135057.","journal-title":"Cancer Res"},{"key":"BFcddis2017273_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong WX, Rabinowitz JD, White E . Mitochondria and cancer. Mol Cell 2016; 61: 667\u2013676.","journal-title":"Mol Cell"},{"key":"BFcddis2017273_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12185-016-1968-4","volume":"103","author":"A Kondo","year":"2016","unstructured":"Kondo A, Fujiwara T, Okitsu Y, Fukuhara N, Onishi Y, Nakamura Y et al. Identification of a novel putative mitochondrial protein FAM210B associated with erythroid differentiation. Int J Hematol 2016; 103: 387\u2013395.","journal-title":"Int J Hematol"},{"key":"BFcddis2017273_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E . The metabolism of tumors in the body. J Gen Physiol 1927; 8: 519\u2013530.","journal-title":"J Gen Physiol"},{"key":"BFcddis2017273_CR18","first-page":"670","volume":"21","author":"P Som","year":"1980","unstructured":"Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980; 21: 670\u2013675.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"BFcddis2017273_CR19","first-page":"S44","volume":"5","author":"VK Prasanna","year":"2009","unstructured":"Prasanna VK, Venkataramana NK, Dwarakanath BS, Santhosh V . Differential responses of tumors and normal brain to the combined treatment of 2-DG and radiation in glioablastoma. J Cancer Res Ther 2009; 5 ((Suppl 1)): S44\u2013S47.","journal-title":"J Cancer Res Ther"},{"key":"BFcddis2017273_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ccell.2016.02.018","volume":"29","author":"RV Pusapati","year":"2016","unstructured":"Pusapati RV, Daemen A, Wilson C, Sandoval W, Gao M, Haley B et al. mTORC1-dependent metabolic reprogramming underlies escape from glycolysis addiction in cancer cells. Cancer Cell 2016; 29: 548\u2013562.","journal-title":"Cancer Cell"},{"key":"BFcddis2017273_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.celrep.2014.06.043","volume":"8","author":"PE Porporato","year":"2014","unstructured":"Porporato PE, Payen VL, Perez-Escuredo J, De Saedeleer CJ, Danhier P, Copetti T et al. A mitochondrial switch promotes tumor metastasis. Cell Rep 2014; 8: 754\u2013766.","journal-title":"Cell Rep"},{"key":"BFcddis2017273_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB . The emerging hallmarks of cancer metabolism. Cell Metab 2016; 23: 27\u201347.","journal-title":"Cell Metab"},{"key":"BFcddis2017273_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2049-3002-2-20","volume":"2","author":"Y Sun","year":"2014","unstructured":"Sun Y, Daemen A, Hatzivassiliou G, Arnott D, Wilson C, Zhuang G et al. Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells. Cancer Metab 2014; 2: 20.","journal-title":"Cancer Metab"},{"key":"BFcddis2017273_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"MH Yang","year":"2008","unstructured":"Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10: 295\u2013305.","journal-title":"Nat Cell Biol"},{"key":"BFcddis2017273_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2011.11.024","volume":"21","author":"VG Cooke","year":"2012","unstructured":"Cooke VG, LeBleu VS, Keskin D, Khan Z, O'Connell JT, Teng Y et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 2012; 21: 66\u201381.","journal-title":"Cancer Cell"},{"key":"BFcddis2017273_CR26","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1038\/nprot.2006.273","volume":"1","author":"B Cox","year":"2006","unstructured":"Cox B, Emili A . Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat Protoc 2006; 1: 1872\u20131878.","journal-title":"Nat Protoc"},{"key":"BFcddis2017273_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ncb2488","volume":"14","author":"RM Perciavalle","year":"2012","unstructured":"Perciavalle RM, Stewart DP, Koss B, Lynch J, Milasta S, Bathina M et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat Cell Biol 2012; 14: 575\u2013583.","journal-title":"Nat Cell Biol"},{"key":"BFcddis2017273_CR28","first-page":"2125","volume":"42","author":"AB Cordero","year":"2010","unstructured":"Cordero AB, Kwon Y, Hua X, Godwin AK . In vivo imaging and therapeutic treatments in an orthotopic mouse model of ovarian cancer. J Vis Exp 2010; 42: 2125.","journal-title":"J Vis Exp"},{"key":"BFcddis2017273_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ccr.2011.01.019","volume":"19","author":"JP Theurillat","year":"2011","unstructured":"Theurillat JP, Metzler SC, Henzi N, Djouder N, Helbling M, Zimmermann AK et al. URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell 2011; 19: 317\u2013332.","journal-title":"Cancer Cell"},{"key":"BFcddis2017273_CR30","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/jnci\/djn213","volume":"100","author":"J Xing","year":"2008","unstructured":"Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J et al. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst 2008; 100: 1104\u20131112.","journal-title":"J Natl Cancer Inst"}],"updated-by":[{"DOI":"10.1038\/s41419-019-1945-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2017273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017273","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cddis.2017.273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:52:18Z","timestamp":1671731538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2017273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["BFcddis2017273"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2017.273","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41419-019-1945-y","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]},"assertion":[{"value":"28 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}